Group One Trading
RNAC icon

Group One Trading’s Cartesian Therapeutics RNAC Stock Holding History

Group One Trading’s Portfolio RNAC Stock Details RNAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-13
Closed -$275 – 7834
2023
Q4 		$275 Hold
13
– – ﹤0.01% 7140
2023
Q3 		$424 Buy
+13
New +$434 ﹤0.01% 7360
2023
Q2 		– Sell
-7
Closed -$278 – 8128
2023
Q1 		$278 Buy
+7
New +$329 ﹤0.01% 6971
2022
Q4 		– Sell
-1,040
Closed -$51K – 7969
2022
Q3 		$51K Buy
1,040
+660
+174% +$36.2K ﹤0.01% 5395
2022
Q2 		$15K Buy
380
+117
+44% +$3.47K ﹤0.01% 6519
2022
Q1 		$10K Buy
263
+13
+5% +$813 ﹤0.01% 7167
2021
Q4 		$24K Sell
250
-233
-48% -$25.1K ﹤0.01% 6872
2021
Q3 		$60K Sell
483
-2,350
-83% -$284K ﹤0.01% 6393
2021
Q2 		$355K Buy
2,833
+1,640
+137% +$195K ﹤0.01% 4597
2021
Q1 		$162K Buy
1,193
+986
+476% +$122K ﹤0.01% 5229
2020
Q4 		$19K Buy
+207
New +$17.9K ﹤0.01% 5555
2020
Q3 		– Sell
-667
Closed -$57K – 6491
2020
Q2 		$57K Buy
+667
New +$60.5K ﹤0.01% 4272
2019
Q3 		– Sell
-163
Closed -$9K – 5472
2019
Q2 		$9K Hold
163
– – ﹤0.01% 4459
2019
Q1 		$12K Buy
+163
New +$10.3K ﹤0.01% 4213
2018
Q3 		– Sell
-17
Closed -$7K – 5557
2018
Q2 		$7K Buy
+17
New +$6.03K ﹤0.01% 4730

Other funds holding RNAC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
PFM
Privium Fund Management Amsterdam, Netherlands $480M AUM 77.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Group One Trading's RNAC Position: Q2 2024 in Review

Group One Trading sold out of Cartesian Therapeutics (RNAC) in Q2 2024, closing a stake of 94 shares — an estimated $2.24K sold.

Group One Trading first reported a position in RNAC in Q3 2018 and held it in 19 quarters. The position peaked at $348K in Q2 2021. 61 funds tracked by Wall St. Rank hold RNAC as of Q2 2024.

  • Group One Trading reported no remaining Cartesian Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Group One Trading sold 94 Cartesian Therapeutics shares in Q2 2024, an estimated $2.24K.
  • Group One Trading first reported a position in Cartesian Therapeutics in Q3 2018 and held it in 19 quarters.
  • Group One Trading's Cartesian Therapeutics position peaked at $348K in Q2 2021.
  • 61 funds tracked by Wall St. Rank held Cartesian Therapeutics as of Q2 2024.

Based on Group One Trading's 13F filing for Q2 2024, filed 14 Aug 2024.